Avinger, Inc. (AVGR)
NASDAQ: AVGR · Real-Time Price · USD
0.790
+0.010 (1.28%)
Nov 4, 2024, 4:00 PM EST - Market closed
Avinger Employees
As of December 31, 2023, Avinger had 72 total employees, including 68 full-time and 4 part-time employees. The number of employees decreased by 3 or -4.00% compared to the previous year.
Employees
72
Change (1Y)
-3
Growth (1Y)
-4.00%
Revenue / Employee
$103,181
Profits / Employee
-$213,028
Market Cap
1.81M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China SXT Pharmaceuticals | 75 |
cbdMD | 52 |
FOXO Technologies | 29 |
Helius Medical Technologies | 22 |
Tenon Medical | 21 |
Altamira Therapeutics | 10 |
Dermata Therapeutics | 8 |
SCWorx | 7 |
AVGR News
- 6 days ago - Avinger to Announce Third Quarter 2024 Results on November 7, 2024 - Accesswire
- 11 days ago - Avinger Releases Updated Data From IMAGE-BTK in Webinar Featuring Key Opinion Leaders in the Field of Vascular Intervention - Accesswire
- 6 weeks ago - Avinger Announces Issuance of New U.S. Patent and Receives Notices of Allowance for Five Additional U.S. Patents - Accesswire
- 2 months ago - Avinger Initiates Full Commercial Launch of Pantheris LV Image-Guided Atherectomy Device - Accesswire
- 3 months ago - Avinger, Inc. (AVGR) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Avinger Reports Second Quarter 2024 Results - Accesswire
- 3 months ago - Avinger Appoints Thomas P. Davis, MD, FACC as Chief Medical Officer - Accesswire
- 3 months ago - Avinger to Announce Second Quarter 2024 Results on August 8, 2024 - Accesswire